Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
life sciences
startups
bioinnovation capital
biolabs
biotech & health
boston
boston blog main
chemotherapy
daraprim
deals
drug pricing
drugs
epipen
epipens
exome
gene therapy
generic drugs
genetic testing
insulin
invitae
johannes fruehauf
labcentral
life science
martin shkreli
mylan
national blog main
national xcon
non-invasive prenatal tests
novartis
oncology
peter kolchinsky
prenatal tests
price collusion
san francisco
san francisco blog main
san francisco top stories
singular bio
spinal muscular atrophy
stem cells
What
medical
wide
3
×
bio
cost
investment
ability
accelerating
acquire
alleviate
area
array
babies
biotech
bounds
business
cells
clearly
conditions
controversial
controversy
deal
driving
drug
expand
futuristic
generating
genetic
good
grown
hailed
harvesting
healthcare
history
human
improved
industrial
industry
innovation
innovations
invitae
Language
unset
Current search:
wide
×
biotech
×
@techcrunch.com
1 month ago
This Swedish startup wants to reduce the cost, and controversy, around stem cells production
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
4 years ago
Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business
